1,795 results on '"Park, Hae-Sim"'
Search Results
2. Adverse Impacts of Corticosteroid Treatment on Osteoporosis/Osteopenia in Adult Asthmatics: A Retrospective ICARUS Cohort Study
3. Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis
4. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
5. Serum Galectin-10: A biomarker for persistent airflow limitation in adult asthmatics
6. Downregulation of otulin induces inflammasome activation in neutrophilic asthma
7. Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia
8. 8-Iso-prostaglandin F2α as a biomarker of type 2 low airway inflammation and remodeling in adult asthma
9. The effect of Bruton’s tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse
10. Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study
11. Work-related asthma in adults with severe asthma from the Korean Severe Asthma Registry (KoSAR)
12. HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity
13. Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma by inhibiting the JNK pathway in airway epithelium
14. Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma
15. Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study
16. Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice
17. Prediction of the number of asthma patients using environmental factors based on deep learning algorithms
18. Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease
19. Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma
20. Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma
21. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
22. Micrococcus luteus-derived extracellular vesicles attenuate neutrophilic asthma by regulating miRNAs in airway epithelial cells
23. Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice
24. Calcium ionophore-activated platelets induce eosinophil extracellular trap formation
25. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
26. Endocrine-disrupting chemical exposure augments neutrophilic inflammation in severe asthma through the autophagy pathway
27. Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid–Formoterol in Asthmatics
28. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study
29. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study
30. Mono-n-butyl phthalate regulates nuclear factor erythroid 2–related factor 2 and nuclear factor kappa B pathway in an ovalbumin-induced asthma mouse model
31. Gut permeability and its correlation with patient's traits and blood inflammatory markers in severe asthma: Real‐world assessment from the Korean severe asthma registry‐2 (KoSAR‐2).
32. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
33. Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy
34. Update on latex allergy: New insights into an old problem
35. Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma
36. Longitudinal Outcomes of Severe Asthma: Real-World Evidence of Multidimensional Analyses
37. S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma
38. Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma
39. Toward personalization of asthma treatment according to trigger factors
40. COVID-19, asthma, and biological therapies: What we need to know
41. 8-Iso-prostaglandin F2α as a biomarker of T2-low airway inflammation and remodeling in adult asthma
42. New targets for type 2-low asthma
43. Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients
44. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
45. Impairment and Disability Evaluations
46. Real-world treatment trajectories of adults with newly diagnosed asthma or COPD
47. The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma
48. Transforming growth factor-β1 and eosinophil-derived neurotoxins contribute to the development of work-related respiratory symptoms in bakery workers
49. Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation
50. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.